Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Dokumenty

Y0000420

Cefotaxime acid

European Pharmacopoeia (EP) Reference Standard

Synonim(y):

Cefotaxime

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
Wszystkie zdjęcia(1)

About This Item

Wzór empiryczny (zapis Hilla):
C16H17N5O7S2
Numer CAS:
63527-52-6
Masa cząsteczkowa:
455.47
Numer WE:
264-299-1
Kod UNSPSC:
41116107
NACRES:
NA.24

klasa czystości

pharmaceutical primary standard

rodzina API

cefotaxime

producent / nazwa handlowa

EDQM

Zastosowanie

pharmaceutical (small molecule)

format

neat

temp. przechowywania

2-8°C

InChI

1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m0./s1

Klucz InChI

AZZMGZXNTDTSME-XJTDMATHSA-M

Opis ogólny

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Zastosowanie

Cefotaxime acid EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Opakowanie

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Inne uwagi

Sales restrictions may apply.
This page may contain text that has been machine translated.

Kod klasy składowania

11 - Combustible Solids

Klasa zagrożenia wodnego (WGK)

WGK 3

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Przepraszamy, ale COA dla tego produktu nie jest aktualnie dostępny online.

Proszę o kontakt, jeśli potrzebna jest pomoc Obsługa Klienta

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Klienci oglądali również te produkty

Slide 1 of 7

1 of 7

Cefuroxime VETRANAL®, analytical standard

Supelco

34218

Cefuroxime

Ceftazidime Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1847

Ceftazidime

Ceftazidime

Sigma-Aldrich

CDS020667

Ceftazidime

Noradrenaline tartrate European Pharmacopoeia (EP) Reference Standard

N1100000

Noradrenaline tartrate

Tazobactam sodium salt β-lactamase inhibitor

Sigma-Aldrich

T2820

Tazobactam sodium salt

Potassium clavulanate VETRANAL®, analytical standard

Supelco

33454

Potassium clavulanate

Ciprofloxacin ≥98% (HPLC)

Sigma-Aldrich

17850

Ciprofloxacin

C Delangle et al.
Medecine et maladies infectieuses, 43(6), 244-247 (2013-06-29)
We had for aim to check the appropriateness of our practices according to French guidelines (17th consensus conference, SPILF 2008) and to identify variables associated with the delay before appropriate measures were implemented. Our retrospective observational study (2009-2011) focused on
Martijn F Schenk et al.
Molecular biology and evolution, 30(8), 1779-1787 (2013-05-17)
Understanding epistasis is central to biology. For instance, epistatic interactions determine the topography of the fitness landscape and affect the dynamics and determinism of adaptation. However, few empirical data are available, and comparing results is complicated by confounding variation in
Elad Firnberg et al.
Nucleic acids research, 41(15), 7420-7428 (2013-06-12)
An important goal of evolutionary biology is to understand the constraints that shape the dynamics and outcomes of evolution. Here, we address the extent to which the structure of the standard genetic code constrains evolution by analyzing adaptive mutations of
Christine Ferreiro et al.
European journal of pediatrics, 172(9), 1243-1248 (2013-05-17)
The treatment of complicated urinary tract infection in children is still a matter of debate. In our hospital, antimicrobial treatment is initiated intravenously, and the duration of this treatment is adapted according to the results of a Tc-99m dimercaptosuccinic acid
Suresh Ramasamy et al.
Journal of tropical pediatrics, 60(1), 83-86 (2013-09-26)
To compare the effectiveness of two antibiotic regimens among neonates with late onset sepsis (LOS). This randomized controlled trial conducted in a tertiary care teaching hospital, South India, included 90 babies with LOS. Detailed history, examination and appropriate investigations were
Wyświetl wszystkie powiązane dokumenty

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej